The adverse effect of perioperative brimonidine tartrate 0.2% on Flap adherence and enhancement rates in laser in situ keratomileusis patients

Ophthalmology

Volumn 108, Issue 8, 2001, Pages 1434-1438

  Walter, Keith A ^a   Gilbert, David D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; PROXYMETACAINE;

ADULT; ARTICLE; CORNEA INJURY; DRUG INSTILLATION; FEMALE; HUMAN; KERATOMILEUSIS; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISUAL ACUITY;

ADHESIONS; ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; CORNEAL DISEASES; CORNEAL STROMA; FEMALE; HUMANS; KERATOMILEUSIS, LASER IN SITU; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PREOPERATIVE CARE; QUINOXALINES; REFRACTIVE ERRORS; RETROSPECTIVE STUDIES; SURGICAL FLAPS; VISUAL ACUITY;

EID: 0034902176     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00627-3     Document Type: Article

References (7)

1. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients
2. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty
3. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation after anterior segment laser procedures
4. α2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration
5. Laser in situ keratomileusis flap complications and management
6. Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis cases
7. Effect of brimonidine tartrate on ocular hemodynamic measurements